High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs

Tony P Huang1,2,3, Zachary J Heins4,5, Shannon M Miller1,2,3

  • 1Merkin Institute of Transformative Technologies in Healthcare, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Nature Biotechnology
|September 8, 2022
PubMed